Mohammed Sary Naga

Dr. Mohammed Sary Naga


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BRBestun Rashid
Bestun Rashid
MNMohammed Sary Naga
Mohammed Sary Naga
KKKonrad Kobryń
Konrad Kobryń
MGMichał Grąt
Michał Grąt
Background/Objectives: Living donor liver transplantation (LDLT) has emerged as an alternative to deceased donor liver transplantation (DDLT) in the circumstance of scarcity of deceased grafts. This systematic review and meta-analysis aims to compare outcomes between LDLT and DDLT in adult recipients. Methods: This systematic review was conducted in accordance with the PRISMA 2020 guidelines. A systematic literature search was performed using PubMed, EMBASE, and manual reference screening of relevant articles. We included peer-reviewed cohort studies comparing LDLT and DDLT in adult patients (≥18 years), published in English since 2015. Results: A total of 17 cohort studies, published between 2015 and 2024, fulfilled the inclusion criteria and were included in this systematic review and meta-analysis. These studies included a total of 22,514 adult liver transplant recipients, of whom 3832 (17.02%) and 18,682 (82.98%) underwent LDLT and DDLT, respectively. In comparison with DDLT, LDLT was associated with better 1-year patient survival, 5-year patient survival, and 5-year graft survival; however, these findings are based on low-certainty evidence and may be influenced by selection bias and baseline differences between cohorts. There were no significant differences between LDLT and DDLT groups in 3-year patient survival, 1-year graft survival, re-transplantation rates, biliary leakage, biliary stricture, or infection rates. Conclusions: LDLT is a valuable alternative to DDLT, particularly in regions with limited access to deceased donor organs, as it provides an excellent alternative to DDLT without compromising recipient outcomes, though further high-quality studies are needed.